Formosa Laboratories EBIT

Formosa Laboratories (4746.TW) currently reports a EBIT of $860M as of June 2026. That compares with $120M in the prior-year period — up 595.6% year over year. That is below the sector sector average of $2.6T. Use the charts on this page to explore Formosa Laboratories's EBIT history and peer comparisons.

Formosa Laboratories's EBIT increased from $120M to $860M — a 595.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Formosa Laboratories's EBIT of $860M is lower than the its sector sector average of $2.6T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Formosa Laboratories reported $860M in EBIT as of June 2026. That compares with $120M in the prior-year period — up 595.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $860M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.6T. From there, open related valuation or income-statement pages for Formosa Laboratories, and consider following 4746.TW for alerts when major investors trade the stock.